Correlation Between Black Diamond and Travere Therapeutics
Can any of the company-specific risk be diversified away by investing in both Black Diamond and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Black Diamond and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Black Diamond Therapeutics and Travere Therapeutics, you can compare the effects of market volatilities on Black Diamond and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Black Diamond with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Black Diamond and Travere Therapeutics.
Diversification Opportunities for Black Diamond and Travere Therapeutics
-0.91 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Black and Travere is -0.91. Overlapping area represents the amount of risk that can be diversified away by holding Black Diamond Therapeutics and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and Black Diamond is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Black Diamond Therapeutics are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of Black Diamond i.e., Black Diamond and Travere Therapeutics go up and down completely randomly.
Pair Corralation between Black Diamond and Travere Therapeutics
Given the investment horizon of 90 days Black Diamond Therapeutics is expected to under-perform the Travere Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Black Diamond Therapeutics is 1.03 times less risky than Travere Therapeutics. The stock trades about -0.25 of its potential returns per unit of risk. The Travere Therapeutics is currently generating about 0.25 of returns per unit of risk over similar time horizon. If you would invest 960.00 in Travere Therapeutics on September 2, 2024 and sell it today you would earn a total of 921.00 from holding Travere Therapeutics or generate 95.94% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Black Diamond Therapeutics vs. Travere Therapeutics
Performance |
| Timeline |
| Black Diamond Therap |
| Travere Therapeutics |
Black Diamond and Travere Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Black Diamond and Travere Therapeutics
The main advantage of trading using opposite Black Diamond and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Black Diamond position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.| Black Diamond vs. Passage Bio | Black Diamond vs. Alector | Black Diamond vs. Revolution Medicines | Black Diamond vs. Stoke Therapeutics |
| Travere Therapeutics vs. Tff Pharmaceuticals | Travere Therapeutics vs. Eliem Therapeutics | Travere Therapeutics vs. Inhibrx | Travere Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Stocks Directory Find actively traded stocks across global markets |